Posted inBiotechnology
Home-Based Kits: Insights on Autism Diagnosis Factors
In an era where convenience meets scientific exploration, a groundbreaking study has emerged that delves into community perceptions surrounding home-based…
Posted inBiotechnology
Evaluating the Eating Behavior and Appetite Questionnaire
In a significant stride towards understanding and addressing obesity, researchers have recently published a comprehensive study detailing the development and…
Posted inBiotechnology
Mindfulness Eases Anxiety, Improves Sleep for Caregivers
In a groundbreaking study published in the forthcoming edition of BMC Nursing, researchers investigated the profound impact of mindfulness-based stress…
Posted inBiotechnology
Neurogenic Dysfunction Syndrome Post-Acute Brain Injury
In the evolving landscape of neuroscience, a significant challenge arises following acute brain injury, where patients often experience a complex…
Posted inBiotechnology
Triploidy Effects on Sea Bass Development Revealed
In a groundbreaking study poised to make waves in the field of marine genetics, researchers from Spain have unveiled the…
Posted inBiotechnology
Myocarditis in Child After Scorpion Sting: Case Study
A recent case report highlights the alarming medical consequences of scorpion stings, specifically focusing on a rare condition known as…
Posted inBiotechnology
HIIT Boosts Mental Health and Sleep in College Women
Recent research has shed light on the intersection of physical fitness and mental health, particularly in the context of high-intensity…
Posted inBiotechnology
Cumulative Blood Pressure Linked to Cognitive Decline in Seniors
In a groundbreaking study set to be published in the esteemed journal BMC Geriatrics, researchers have uncovered significant connections between…
Posted inBiotechnology
Sana, CAMP4 ditch clinical-stage assets for more promising preclinical candidates
Sana Biotechnology, CAMP4 Therapeutics and Crinetics Pharmaceuticals have all used the third quarter to refocus their pipelines on the most…
Posted inBiotechnology
Patient dies after receiving Intellia’s CRISPR therapy
The patient who was hospitalized after receiving Intellia Therapeutics’ CRISPR therapy nex-z has died. Both phase 3 studies of the…